Research @ UVA Engineering

George Joseph Christ, Ph.D., develops basic and translational tissue engineering and regenerative medicine approaches to organ and tissue repair, reconstruction and replacement, with a focus on the musculoskeletal system, vasculature and lower urinary tract. Dr. Christ is an internationally recognized expert in muscle physiology.

Alex Clark, Ph.D., is a cell biologist and engineer who studies gene expression dynamics and molecular networks that drive heart development and function. 

Christopher Deppman has been interested in the mechanisms underlying long-distance signaling in the context of nervous system development since he was a post-doctoral fellow at Johns Hopkins University School of Medicine in the laboratory of David Ginty (now at Harvard). 

Prior to joining UVA as an Associate Professor in 2012, Dr. Dong was an associate professor of Mechanical Engineering at the Wright State University. He obtained his Ph.D. degree in Aerospace Engineering from UCLA in 2003. After completing his doctorate, he spent three years as a post-doctoral researcher at the George Washington University.

Afsaneh Doryab's research is at the intersection of ubiquitous computing, AI, HCI, and health. She works on computational modeling of human behavior (incl. Activity Recognition) from data streams collected via mobile, wearable, and embedded sensors. 

Ph.D. in Science, Technology, and Society from Virginia Tech. Research areas include: History of Eugenics, Regenerative and Genetic Medicine, Transhumanism, Cyborgs, and Future Imaginaries. Scholarly Fields include: Philosophy of Technology, Medical Humanities, Media Studies, Disability Studies.

Dr. Epstein is a world leader in advancing MRI myocardial strain imaging by developing and applying the cine DENSE (displacement encoding using stimulated echoes) MRI method.

For information about me and my research, please see my web page and research group blog.

Dr. Fallahi-Sichani leads a Systems Biology research program aiming to discover the fundamental mechanisms through which human cancer cells respond heterogeneously to environmental and therapeutic perturbations.